骨髓瘤患者在治疗期间和治疗后的身体活动:单站点前性观察性研究
Elysia R Cohen1, Clark Andersen2, Karen Moody1
1Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cancer medicine
|February 26, 2026
概括
患有骨肉瘤的儿童在治疗期间表现出较低的体力活动. 将运动计划与治疗计划相适应可能会改善儿童癌症患者的治疗结果和生活质量.
科学领域:
- 儿科瘤学 儿科瘤学
- 康复医学 康复医学 康复医学
- 癌症的生存率 癌症的生存率
背景情况:
- 骨髓瘤是一种常见的儿童骨癌,影响患者的生活质量.
- 有限的数据存在于儿童骨髓瘤患者在治疗期间的身体活动.
- 运动干预措施对癌症患者来说是有前途的,但需要针对这一群体的具体数据.
研究的目的:
- 了解患有骨髓瘤的儿童和青少年的体育活动模式.
- 在整个治疗和生存连续过程中,为设计有效的运动干预措施提供信息.
- 评估与治疗阶段有关的活动水平.
主要方法:
- 使用可穿戴活动追踪器来监测骨髓瘤患者的身体活动.
- 包括标准包括所有年龄,性别和治疗阶段,包括治疗后.
- 需要至少3天的有效数据,连续监测心率超过10小时.
主要成果:
- 26名患者提供了有效的活动数据.
- 平均每日步骤在治疗日为3184±2553,在治疗结束日为4884±2447.
- 大多数患者保持在建议的每日步数以下,直到治疗完成后.
结论:
- 儿科骨髓瘤患者的身体活动水平在治疗期间通常很低.
- 运动计划可能受益于在化疗日鼓励活动,并在治疗后安排强度运动.
- 进一步的研究是必要的,以开发有针对性的干预措施,以提高这一群体的身体活动.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...


